Chief Executive Officer
Christopher Parker’s career in the medical diagnostic and device industry spans more than 30 years. Having worked all over the world (including Australia, Singapore, India, Canada and the UK) in a variety of laboratory and commercial roles, he has developed substantial global experience of diverse healthcare environments and has a keen interest in emerging technologies. Beginning his career as a Medical Laboratory Scientist in Australia, Christopher then moved to the commercial sector in a business management role in medical diagnostics. He spent almost 14 years in the in-vitro diagnostics industry before moving to a diagnostic imaging company Christopher joined Roche Diagnostics in 1997 and over the next seven years held roles of increasing scope and responsibility in sales, marketing and business development across the Asia Pacific region. He was appointed General Manager of Roche Diagnostics Canada in 2007 and Managing Director of Roche’s UK and Ireland diagnostics affiliate in 2012. In 2013 and alongside his UK Managing Director role, he was appointed Head of Roche’s Management Centre for European Agents with responsibility for the distributor businesses in Cyprus, Iceland, Israel and Malta. In 2017, Christopher retired from Roche Diagnostics, moved back to Australia and has since formed Stratigent Consulting, an organisation that specialises in providing customised, professional advice in the areas of: Business and Strategy Development; Organisational Culture and Change Management and People Leadership and Coaching.
Chief Financial Officer
Mr McInally has been a chartered accountant for 20 years working in both the profession and commerce. Glenn has held the positions of Manager, Senior Manager, Executive and Director at several Accounting practices before cofounding McVinish McInally SME Accountants Pty Ltd. Previously to becoming CFO, Mr McInally worked on various projects for Anteo over a span of 15 months
Chief Scientific Officer
Dr Joe Maeji has more than 20 years experience managing successful R&D projects in the biotechnology and life science industries. His focus has been on the commercialisation of products and technologies at the interface of chemistry and biology. He has significant experience in successfully securing funding for the development of new technologies, as well as in creating and securing extensive IP portfolios. Joe was a co-founder and founding CEO of the Bio-Layer Pty Ltd company that became Anteo Technologies.
Head of R&D
Dr Charlie Huang has more than 20 years experience in multi-discipline research and development. He has demonstrated scientific expertise in protein engineering, molecular biology, enzyme kinetics, drug discovery, bio-conjugation, bio-separation, immunoassay development, rapid and point of care diagnostics and nano-biotechnology. He also has significant commercial expertise in project management, technology analysis, licensing and intellectual proprieties management.